CI & Patent News: 06/12/2010


1) Paragraph IV litigation

Hoffmann-LaRoche Inc. v. Apotex Inc (ibandronate sodium)

Complaint filed at District of New Jersey on Dec. 2, 2010 View on PriorSmart

Shire LLC, Supernus Pharmaceuticals, Incl et. al. v. IMPAX Laboratories, Inc & Watson (Guanfacine HCl)

Complaint filed at District Court of Northern District of California on Dec. 2, 2010 View on PriorSmart

Medicis Vs Aurobindo (Minocycline HCl)

Complaint filed at district court of Delaware on ???? (Boolmberg)

2) Advinus announces tie-up with Corning India; Advinus is an indian company (TATA group) involved in drug discovery & development and Corning’s Epic® System is a high-throughput label-free screening platform based on optical biosensor technology. The system performs both biochemical and cell-based drug discovery applications and offers drug developers the ability to evaluate promising new drug targets. (Press release)

3) Imatinib Indian case:  Supreme court, on friday, asked defendants (Cipla, Ranbaxy Lab, Hetero Drugs, Natco) to complete formalities on Imatinib appeal case by Novartis. This is an appeal filed on IPAB’s order on rejecting imatinib’s beta crystalline form application (1602/MAS/1998).

4) Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia (Link)

5) Marketing Collaboration on Protopic® Ointment for Treatment of Atopic Dermatitis in Japan (Astellas press release)

6) Patent landscape on Anti-aging skin care by Patent insight pro (india invents)

7) RG1678: Phase II study with first-in-class investigational drug demonstrates improvement in negative symptoms in patients with schizophrenia (Roche Press Release)

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s